CY1108978T1 - Συνδυασμος ενωσεων μεθυλξανθινης και στεροειδων για να θεραπευονται χρονιες αναπνευστικες ασθενειες - Google Patents

Συνδυασμος ενωσεων μεθυλξανθινης και στεροειδων για να θεραπευονται χρονιες αναπνευστικες ασθενειες

Info

Publication number
CY1108978T1
CY1108978T1 CY20091100435T CY091100435T CY1108978T1 CY 1108978 T1 CY1108978 T1 CY 1108978T1 CY 20091100435 T CY20091100435 T CY 20091100435T CY 091100435 T CY091100435 T CY 091100435T CY 1108978 T1 CY1108978 T1 CY 1108978T1
Authority
CY
Cyprus
Prior art keywords
combination
methylxanthine
treat chronic
chronic respiratory
respiratory illnesses
Prior art date
Application number
CY20091100435T
Other languages
English (en)
Inventor
Justian Craig Fox
Original Assignee
Argenta Discovery Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0502949A external-priority patent/GB0502949D0/en
Priority claimed from GB0526124A external-priority patent/GB0526124D0/en
Application filed by Argenta Discovery Limited filed Critical Argenta Discovery Limited
Publication of CY1108978T1 publication Critical patent/CY1108978T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Παρέχεται η χρήση ενός παραγώγου μεθυλξανθίνης όπως θεοφυλλίνης και ενός στερεοειδούς σε έναν συνεργιστικό συνδυασμό για τη θεραπεία χρόνιας αποφρακτικής πνευμονοπάθειας, όπου ο συνδυασμός χορηγείται με τον εισπνεόμενο τρόπο για πνευμονική απελευθέρωση.
CY20091100435T 2005-02-11 2009-04-13 Συνδυασμος ενωσεων μεθυλξανθινης και στεροειδων για να θεραπευονται χρονιες αναπνευστικες ασθενειες CY1108978T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0502949A GB0502949D0 (en) 2005-02-11 2005-02-11 Combination therapy
GB0526124A GB0526124D0 (en) 2005-12-22 2005-12-22 Inhaled combination therapy
EP06709719A EP1845994B1 (en) 2005-02-11 2006-02-13 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases

Publications (1)

Publication Number Publication Date
CY1108978T1 true CY1108978T1 (el) 2013-09-04

Family

ID=36123283

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100435T CY1108978T1 (el) 2005-02-11 2009-04-13 Συνδυασμος ενωσεων μεθυλξανθινης και στεροειδων για να θεραπευονται χρονιες αναπνευστικες ασθενειες

Country Status (21)

Country Link
US (2) US8431553B2 (el)
EP (1) EP1845994B1 (el)
JP (1) JP5579368B2 (el)
CN (1) CN102526074B (el)
AT (1) ATE421325T1 (el)
AU (1) AU2006212022B2 (el)
BR (1) BRPI0606736A2 (el)
CA (1) CA2597384C (el)
CY (1) CY1108978T1 (el)
DE (1) DE602006004963D1 (el)
DK (1) DK1845994T3 (el)
ES (1) ES2321554T3 (el)
IL (1) IL183696A (el)
MX (1) MX2007009698A (el)
NO (1) NO338765B1 (el)
NZ (1) NZ555780A (el)
PL (1) PL1845994T3 (el)
PT (1) PT1845994E (el)
RU (1) RU2395285C2 (el)
SI (1) SI1845994T1 (el)
WO (1) WO2006085102A1 (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
WO2008095136A2 (en) 2007-01-31 2008-08-07 Henkin Robert I Methods for detection of biological substances
NZ560460A (en) * 2007-08-07 2008-11-28 Ib Rosendal Andersen Stock prodder
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
US20100092397A1 (en) * 2008-10-14 2010-04-15 Activaero Gmbh Method For Treatment of COPD and Other Pulmonary Diseases
US20100169259A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100168602A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100169260A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US8712794B2 (en) * 2008-12-30 2014-04-29 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US8694330B2 (en) * 2008-12-30 2014-04-08 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100163027A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100168525A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163025A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100163034A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100166613A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US9724483B2 (en) * 2008-12-30 2017-08-08 Gearbox, Llc Method for administering an inhalable compound
US8738395B2 (en) 2008-12-30 2014-05-27 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100163036A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8725529B2 (en) * 2008-12-30 2014-05-13 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US8706518B2 (en) * 2008-12-30 2014-04-22 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CA2777245A1 (en) * 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
KR20140054066A (ko) 2011-07-15 2014-05-08 뉴서트 사이언시스, 인크. 대사 경로 조절을 위한 조성물 및 방법
WO2014055801A1 (en) * 2012-10-05 2014-04-10 Henkin Robert I Phosphodiesterase inhibitors for treating taste and smell disorders
WO2014078459A1 (en) 2012-11-13 2014-05-22 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
WO2014113404A1 (en) 2013-01-15 2014-07-24 Nusirt Sciences, Inc. Treating pulmonary conditions
CA2902879C (en) 2013-03-15 2023-09-26 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
EP3108245B1 (en) 2014-02-18 2020-07-22 Robert I. Henkin Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
MX2016011063A (es) 2014-02-27 2016-11-30 Nusirt Sciences Inc Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica.
UA111983C2 (uk) * 2014-04-29 2016-07-11 Микола Іванович Гуменюк Фармацевтична композиція для лікування хронічних обструктивних захворювань легень

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3622M (fr) 1964-05-04 1965-10-18 Inst Rech Scient Irs Association antiallergique.
GB8918297D0 (en) * 1989-08-10 1989-09-20 Beecham Group Plc Novel treatment
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
GB9202519D0 (en) 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
GB2284761A (en) 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
EP1080720A4 (en) 1998-03-05 2002-06-05 Nippon Shinyaku Co Ltd FAT EMULSIONS FOR INHALATIVE ADMINISTRATION
GB0005199D0 (en) * 2000-03-04 2000-04-26 Imp College Innovations Ltd Modulation of histone deacetylase
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US7550133B2 (en) 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US20050026879A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) 2003-07-31 2005-02-24 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026848A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050026890A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
GB0417481D0 (en) * 2004-08-05 2004-09-08 Etiologics Ltd Combination therapy

Also Published As

Publication number Publication date
US8431553B2 (en) 2013-04-30
EP1845994A1 (en) 2007-10-24
BRPI0606736A2 (pt) 2009-07-21
CN102526074A (zh) 2012-07-04
NO338765B1 (no) 2016-10-17
ES2321554T3 (es) 2009-06-08
NO20072920L (no) 2007-11-08
RU2395285C2 (ru) 2010-07-27
US20080318913A1 (en) 2008-12-25
DK1845994T3 (da) 2009-05-04
IL183696A0 (en) 2007-10-31
JP5579368B2 (ja) 2014-08-27
CN102526074B (zh) 2016-05-18
AU2006212022B2 (en) 2011-02-03
MX2007009698A (es) 2007-09-26
IL183696A (en) 2014-03-31
PL1845994T3 (pl) 2009-07-31
DE602006004963D1 (de) 2009-03-12
SI1845994T1 (sl) 2009-06-30
CA2597384C (en) 2014-01-21
WO2006085102A1 (en) 2006-08-17
US20100324002A1 (en) 2010-12-23
US8426393B2 (en) 2013-04-23
CA2597384A1 (en) 2006-08-17
AU2006212022A1 (en) 2006-08-17
EP1845994B1 (en) 2009-01-21
ATE421325T1 (de) 2009-02-15
PT1845994E (pt) 2009-04-13
NZ555780A (en) 2010-11-26
JP2008530071A (ja) 2008-08-07
RU2007130700A (ru) 2009-02-20

Similar Documents

Publication Publication Date Title
CY1108978T1 (el) Συνδυασμος ενωσεων μεθυλξανθινης και στεροειδων για να θεραπευονται χρονιες αναπνευστικες ασθενειες
BRPI0514043A (pt) medicamentos para tratar doença respiratória crÈnica
CY1117571T1 (el) Συνδυασμος αντιχολινεργικων και ανταγωνιστων υποδοχεα λευκοτριενιου για την αγωγη αναπνευστικων νοσηματων
ECSP055855A (es) Medicamentos en polvo para inhalación que contiene una sal de tiotropio y salmeterolxinafoato
DE602005026007D1 (de) Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
CY1108326T1 (el) ΝΕΟΣ ΣΥΝΔΥΑΣΜΟΣ ΑΝΤΙΧΟΛΙΝΕΡΓΙΚΩΝ ΚΑΙ β ΜΙΜΗΤΙΚΩΝ ΓΙΑ ΤΗΝ ΘΕΡΑΠΕΙΑ ΑΝΑΠΝΕΥΣΤΙΚΩΝ ΑΣΘΕΝΕΙΩΝ
BRPI0514255A (pt) derivados de triazolopiridinilsulfanil como inibidores da p38 map quinase
CR10419A (es) Derivados de Pirazolo [3,4-D]-Pirimidina útiles para tratar trastornos respiratorios
UY26959A1 (es) Nuevos polvos para inhalación que contienen tiotropio
DK1326595T3 (da) Administration af resveratrol til at behandle inflammatoriske respiratoriske lidelser
WO2007062186A3 (en) Methods of using small molecule compounds for neuroprotection
BR0209992A (pt) Inibidor de pde4 e um agente anticolinérgico em combinação para o tratamento de doenças obstrutivas das vias respiratórias
ATE541570T1 (de) Kombination von anticholinergika und hemmern von phosphodiesterase typ 4 zur behandlung von atemwegserkrankungen
ECSP066544A (es) Nuevas sales de tiotropio, procedimientos para su preparación, así como formulaciones medicamentosas que las contienen
BR112014029735A2 (pt) forma de dosagem e formulação de abediterol
UY28596A1 (es) Nuevo anhidrato cristalino con accion anticolinergica
MXPA04012728A (es) Deshidroepiandrosterona dihidratada y metodos para el tratamiento de asma o una enfermedad pulmonar obstructiva cronica utilizando composiciones de la misma.
NO20081480L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
UY30935A1 (es) Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones.
NO20073909L (no) Forstover-formulering
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
NO20081483L (no) Kombinasjon av forbindelser som kan brukes ved behandling av respiratoriske sykdommer, spesielt kronisk obstruktiv pulmonaer sykdom (COPD) og astma
MEP51608A (en) Pulverulent formulation for inhalation containing tiotropium
GB2430622A (en) Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases
WO2007046113A3 (en) Novel pharmaceutical composition comprising alkaloid and process thereof